CS logo
small CS logo
JSC K. Eristavi National Center of Experimental and Clinical Surgery

Tbilisi, Georgia
Hospital in Tbilisi
Digomi. k.chachava streets N7 tbilisi, 0159

About JSC K. Eristavi National Center of Experimental and Clinical Surgery


"კ. ერისთავის სახელობის ექსპერიმენტული და კლინიკური ქირურგიის ეროვნული ცენტრი საქართველოში სამედიცინო დაწესებულებათა შორის ერთ-ერთი უძველესია. მისი ისტორია იწყება 1946 წლიდან და სამედიცინო საქმიანობათა ტრადიცია დღემდე უწყვეტად გრძელდება. თანამედროვე მედიცინის მიღწევებზე საუბრისას თვალწინ წარმოგვიდგება უახლესი აპარატურა, თანამედროვე კლინიკები, უნიკალური ოპერაციები, რასაც თან ახლავს პროფესიონალთა დიდი ძალისხმევის ფონზე მიღებული შედეგებით მიღწეული წარმატების უდიდესი ემოცია. თამამად შეიძლება ითქვას, რომ ამ სტანდარტებს სრულად აკმაყოფილებს ჩვენი კლინიკა. ესაა პროგრესულად მოაზროვნე მენეჯმენტის, უახლესი სამედიცინო აპარატურის და, რაც მთავარია, უმაღლესი კვალიფიკაციის პროფესიონალ ექიმთა ერთობლიობა."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Catalyst Biosciences
2
CTI BioPharma
1
Cubist Pharmaceuticals LLC
1
Geron Corporation
1
Janssen Research & Development, LLC
1
Medexus Pharma, Inc.
1
Oncopeptides AB
1
Pacira Pharmaceuticals, Inc
1
Total Rows: 8

Clinical Trials at JSC K. Eristavi National Center of Experimental and Clinical Surgery


During the past decade, JSC K. Eristavi National Center of Experimental and Clinical Surgery conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000022330000000011Started TrialsCompleted Trails2017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy
2007-09-01
2008-07-01
Completed
100
Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
2010-06-25
2011-03-25
Completed
122
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
2017-06-26
2025-12-31
Recruiting
399
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
2017-12-18
2019-04-13
Completed
11
Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B
2020-01-16
2022-07-04
Completed
21
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B
2021-05-04
2021-12-01
Terminated
18
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
2021-04-12
2025-08-27
Recruiting
320
Study of Melphalan Flufenamide (Melflufen) in Combination With Daratumumab in Relapsed Refractory Multiple Myeloma
2020-12-07
2022-02-07
Terminated
54

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" #1 sponsor was "Catalyst Biosciences" with 2 trials, followed by "CTI BioPharma" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored, "Geron Corporation" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" #1 collaborator was "PSI CRO" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCatalyst Biosciences: 2Catalyst Biosciences: 2CTI BioPharma: 1CTI BioPharma: 1Cubist Pharmaceuticals LLC: 1Cubist Pharmaceuticals LLC: 1Geron Corporation: 1Geron Corporation: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Medexus Pharma, Inc.: 1Medexus Pharma, Inc.: 1Oncopeptides AB: 1Oncopeptides AB: 1Pacira Pharmaceuticals, Inc: 1Pacira Pharmaceuticals, Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsPSI CRO: 1PSI CRO: 1

Clinical Trials Conditions at JSC K. Eristavi National Center of Experimental and Clinical Surgery


According to Clinical.Site data, the most researched conditions in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" are "Hemophilia A With Inhibitor" (2 trials), "Hemophilia B With Inhibitor" (2 trials), "Arthritis, Psoriatic" (1 trials), "Complicated Intra-abdominal Infection" (1 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" in a lesser frequency.

Clinical Trials Intervention Types at JSC K. Eristavi National Center of Experimental and Clinical Surgery


Most popular intervention types in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "APVO101" (1 trials), "Best Available Therapy (BAT)" (1 trials), "Bupivacaine HCl" (1 trials), "CXA-101/ tazobactam and metronidazole" (1 trials) and "Coagulation Factor VIIa variant" (1 trials). Other intervention names were less common.

Clinical Trials Genders at JSC K. Eristavi National Center of Experimental and Clinical Surgery


The vast majority of trials in "JSC K. Eristavi National Center of Experimental and Clinical Surgery" are 8 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at JSC K. Eristavi National Center of Experimental and Clinical Surgery


Currently, there are NaN active trials in "JSC K. Eristavi National Center of Experimental and Clinical Surgery". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in JSC K. Eristavi National Center of Experimental and Clinical Surgery, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in JSC K. Eristavi National Center of Experimental and Clinical Surgery, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 3Recruiting: 3Terminated: 2Terminated: 2

Departments of JSC K. Eristavi National Center of Experimental and Clinical Surgery


JSC K. Eristavi National Center of Experimental and Clinical Surgery has several departments that took part in Clinical trials: "National Center of Therapy" - 3 trials
Departments List
Name
City
Trials
Total Rows: 1